Cherie-Ann Nathan, MD, FACS, is the Jack Pou Endowed Professor and Chairman of the Department of Otolaryngology/Head and Neck Surgery at LSU-Health in Shreveport. She is also Director of Head and Neck Oncologic Surgery and Research at the Feist-Weiller Cancer Center. She completed her Otolaryngology/Head and Neck Surgery residency and head and neck fellowship in 1995 at University of California, San Diego. She was a post-doctoral fellow at Johns Hopkins where she started her research career. Following her fellowship she began her academic career at LSU-Shreveport.
Her passion to improve outcomes for patients with head and neck cancer was the reason she moved from Mumbai India, where she went to medical school. She is a Surgeon-Scientist that maintains a busy practice treating head and neck cancer patients, thyroid, parathyroid diseases, salivary gland tumors and voice disorders and also leads an active research team. Her translational research program has been funded by the National Cancer Institute since 2000 and focuses on targeted therapy for head and neck patients. She is nationally and internationally recognized for her seminal work on molecular analysis of surgical margins and has pioneered multi-institutional clinical trials using mTOR inhibitors in HNSCC patients with Wyeth and most recently with Novartis. She has also received NIH funding for chemoprevention of cancer with curcumin and has a patent for a curcumin gum. She is also a team member of the COBRE grant for viral oncogenesis. She has published extensively and has over 170 publications in peer reviewed journals and has authored multiple textbooks and encyclopedia chapters. Read More..